In an interview with the Chinese magazine, Renwu, or People,
Ai Fen, director of the emergency at Wuhan Central hospital: “If I had known what was to happen, I would not have cared about the reprimand. I would have fucking talked about it to whoever, wherever I could.” (She has been missing for several months.)
Ai Fen, director of the emergency at Wuhan Central hospital: “If I had known what was to happen, I would not have cared about the reprimand. I would have fucking talked about it to whoever, wherever I could.” (She has been missing for several months.)
……………………............................................
6-2-20 On May 4, 2020 nations and global philanthropies meeting in Brussels committed $7.4 billion to future pandemic preparedness. But the question hanging over all such investments is this: the remit of the Wuhan lab at the centre of the accidental release claims is pandemic preparedness….
An accidental lab release is not merely a theoretical possibility….
“Take a bat coronavirus that is not infectious to humans, and force its selection by culturing it with cells that express human ACE2 receptor, such cells having been created many years ago to culture SARS coronaviruses and you can force the bat virus to adapt to infect human cells via mutations in its spike protein, which would have the effect of increasing the strength of its binding to human ACE2, and inevitably reducing the strength of its binding to bat ACE2. Viruses in prolonged culture will also develop other random mutations that do not affect its function. The result of these experiments is a virus that is highly virulent in humans but is sufficiently different that it no longer resembles the original bat virus. Because the mutations are acquired randomly by selection there is no signature of a human gene jockey, but this is clearly a virus still created by human intervention.” -Dr. N. Petrovsky
The experiment mentioned by Petrovsky represents a class of experiments called passaging. Passaging is the placing of a live virus into an animal or cell culture to which it is not adapted and then before the virus dies out, transferring it to another animal or cell of the same type. Passaging is often done iteratively.
The theory is that the virus will rapidly evolve (since viruses have high mutation rates) and become adapted to the new animal or cell type. Passaging a virus, by allowing it to become adapted to its new situation, creates a new pathogen….
Only rarely have these(lab viruses) broken out into actual pandemics on the scale of H1N1, which incidentally broke out again in 2009/2010 as “swine flu” causing deaths estimated variously at 3,000 to 200,000 on that occasion (Duggal et al., 2016; Simonsen et al. 2013)….
The second class of experiments that have frequently been the recipients of criticism are GOF experiments. In GOF research, a novel virus is deliberately created, either by in vitro mutation or by cutting and pasting together two (or more) viruses. The intention of such reconfigurations is to make viruses more infectious by adding new functions such as increased infectivity or pathogenicity. These novel viruses are then experimented on, either in cell cultures or in whole animals. Some researchers have even combined GOF and passaging experiments by using recombinant viruses in passaging experiments (e.g. Sheahan et al., 2008)….In 2013 the Shi lab reported isolating an infectious clone of a bat coronavirus that they called WIV-1 (Ge et al., 2013). WIV-1 was obtained by introducing a bat coronavirus into monkey cells, passaging it, and then testing its infectivity in human (HeLa) cell lines engineered to express the human ACE2 receptor (Ge et al., 2013)….In 2017, again with the intent of identifying bat viruses with ACE2 binding capabilities, the Shi lab at WIV reported successfully infecting human (HeLa) cell lines engineered to express the human ACE2 receptor with four different bat coronaviruses. Two of these were lab-made recombinant (chimaeric) bat viruses. Both the wild and the recombinant viruses were briefly passaged in monkey cells (Hu et al., 2017)….[On June 4 an excellent article in the Bulletin of the Atomic Scientists went further. Pointing out what we had overlooked, that the Shi lab also amplified spike proteins of collected coronaviruses, which would make them available for GOF experimentation (Ge et al., 2016).]…
For all these reasons, a lab escape is by far the leading hypothesis to explain the origins of Sars-CoV-2 and the COVID-19 pandemic….it is also dishonest in the sense that Dr. Peter Daszak must know that culturing in the lab is not the only way that WIV researchers could have caused an outbreak. Third, and this is (perhaps) not Daszak’s fault, the media are asking the right question to the wrong person…
The bigger question concerns the current philosophy of pandemic prediction and prevention. Deep enquiries should be made about the overarching wisdom of plucking and counting viruses from the wild and then performing dangerous ‘what if’ recombinant research in high tech but fallible biosafety labs. This is a reductionistic approach, we also note, that has so far failed to predict or protect us from pandemics and may never do so.
-Jonathan Latham, PhD and Allison Wilson, PhD https://www.independentsciencenews.org/health/the-case-is-building-that-covid-19-had-a-lab-origin/
……...............
Jonathan R Latham, PhD is co-founder and Executive Director of the Bioscience Resource Project and the Editor of Independent Science News. Dr Latham is also the Director of the Poison Papers project which publicizes documents of the chemical industry and its regulators. Dr. Latham holds a Masters degree in Crop Genetics and a PhD in Virology. He was subsequently a postdoctoral research associate in the Department of Genetics, University of Wisconsin, Madison. Allison K Wilson, PhD is co-founder and Science Director of the the Bioscience Resource Project; Editor of the Bioscience Resource Project website; Assistant Editor of Independent Science News; and a contributor to the Poison Papers project. Dr. Wilson holds a BA in Biology from Cornell University, a doctorate in Molecular Biology and Genetics from Indiana University, Bloomington, and was formerly a postdoctoral research associate at the Fred Hutchinson Cancer Research Center, Seattle and the John Innes Centre, Norwich, UK.
No comments:
Post a Comment